Gefonib 250mg Tablet

Introduction to Gefonib 250mg Tablet

Gefonib 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients whose cancer has certain gene mutations called EGFR mutations. This tablet is usually prescribed to patients who have not undergone chemotherapy before.

Composition of Gefonib 250mg Tablet

The active ingredient in Gefonib 250mg Tablet is Gefitinib, which is an EGFR tyrosine kinase inhibitor. This means it works by blocking signals that promote cancer cell growth, specifically targeting the mutated EGFR receptors.

Uses of Gefonib 250mg Tablet

• Treatment of locally advanced NSCLC
• Treatment of metastatic NSCLC
• Specifically for patients with EGFR mutations

Side effects of Gefonib 250mg Tablet

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Gefonib 250mg Tablet

Gefonib should not be used by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or those allergic to Gefitinib or any of its ingredients.

How to Take Gefonib 250mg Tablet

• Take one tablet orally once daily.
• Consume at the same time each day for consistency.
• Swallow the tablet whole with water.
• Do not crush or chew the tablet.

Conclusion of Gefonib 250mg Tablet

Gefonib 250mg Tablet is a targeted therapy for certain types of lung cancer, offering hope to patients with specific genetic profiles. While it can be highly effective, it is important to be aware of potential side effects and take necessary precautions. Always follow your healthcare provider's instructions when using this medication.